Intelligent Bio Solutions (NASDAQ: INBS) announced its participation at the RISE25 conference in Kissimmee, Florida, from May ...

Intelligent Bio Solutions reported a Q3 loss of 44 cents per share with a 20% revenue rise from Q2 and 91% year-over-year ...

Likely Trend of INBS Stock Following the News Following the announcement, shares of the company tumbled 5.1% and closed at $1.67 yesterday. In the past six months, INBS’ shares have lost 8.2% ...

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

Detailed price information for Intelligent Bio Solutions Inc (INBS-Q) from The Globe and Mail including charting and trades.

This expected patent will enhance INBS’ existing intellectual property ... public offering of 1,500,000 shares of common stock at a public offering price of $2.00 per share of common stock ...

Vandana Singh EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology Intelligent Bio Solutions (INBS) received a U.S. patent for its fingerprint drug screening ...

Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced the successful completion of a high-volume workforce drug test for Barcaldine Regional Council in remote Queensland, Australia, using its ...

Price Action: At the last check on Tuesday, INBS stock was up 4.92% at $1.28 during the premarket session.